Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Ensure Cardiac Resynchronization Therapy Study

ClinicalTrials.gov ID: NCT00291564

Public ClinicalTrials.gov record NCT00291564. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to gather information on how doctors program particular settings on cardiac resynchronization therapy implantable cardiac defibrillators (CRT-Ds), to analyze how these settings affect the amount of cardiac resynchronization therapy (CRT) patients receive and to evaluate the therapy approach for converting abnormally fast heartbeats into normal heartbeats. There are no experimental devices or procedures involved in this study.

Study identification

NCT ID
NCT00291564
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
430 participants

Conditions and interventions

Conditions

Interventions

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2004 (Type not available)
Primary completion
Not listed
Completion
Feb 2006 (Actual)
Last update posted
Dec 21, 2007

2004 – 2006

United States locations

U.S. sites
32
U.S. states
27
U.S. cities
32
Facility City State ZIP Site status
Not listed Birmingham Alabama — —
Not listed Newport Beach California — —
Not listed Trumbull Connecticut — —
Not listed Daytona Beach Florida — —
Not listed Augusta Georgia — —
Not listed Kankakee Illinois — —
Not listed Indianapolis Indiana — —
Not listed Des Moines Iowa — —
Not listed Owensboro Kentucky — —
Not listed New Orleans Louisiana — —
Not listed Salisbury Maryland — —
Not listed Burlington Massachusetts — —
Not listed Detroit Michigan — —
Not listed Traverse City Michigan — —
Not listed Minneapolis Minnesota — —
Not listed Mexico Missouri — —
Not listed Omaha Nebraska — —
Not listed Bridgewater New Jersey — —
Not listed Englewood New Jersey — —
Not listed Charlotte North Carolina — —
Not listed Dayton Ohio — —
Not listed Lyndhurst Ohio — —
Not listed Oklahoma City Oklahoma — —
Not listed Portland Oregon — —
Not listed Abington Pennsylvania — —
Not listed Doylestown Pennsylvania — —
Not listed Columbia South Carolina — —
Not listed Nashville Tennessee — —
Not listed Houston Texas — —
Not listed Fairfax Virginia — —
Not listed Richmond Virginia — —
Not listed Seattle Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00291564, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 21, 2007 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00291564 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →